Clovis Oncology Inc (NASDAQ:CLVS)

6.97
Delayed Data
As of 3:59pm ET
 -0.51 / -6.82%
Today’s Change
2.93
Today|||52-Week Range
17.37
-33.14%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 6.00, with a high estimate of 23.00 and a low estimate of 4.00. The median estimate represents a -13.92% decrease from the last price of 6.97.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since September, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.00
Sales
$42.5M
Reporting Date
Oct 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 13.04%
 
 
 
 
 
 
Growthannually 41.52%
 
 
 
 
 
 

Sales

Growthquarterly 6.59%
 
 
 
 
 
 
Growthannually 20.24%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.